Last updated on June 2019

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

---

Brief description of study

The overall purpose of this study is to determine the efficacy of fevipiprant (dose 1 and dose 2 once daily), compared with placebo, as add-on to standard-of-care asthma therapy, in terms of avoidance of coricosteroid use over 52 weeks.